2020 to solve a number of key scientific issues restricting the development of Chinese medicine

2017-06-16 12:11:28 Source: Xinhua News Agency China Youth Network

      Xinhua News Agency, Beijing, June 16 (Xinhua Wang Bin, Deng Huaining) acupuncture and copper into the "National Day", artemisinin for the world's millions of patients with the gospel ... ... traditional Chinese medicine "international children" more and more Foot, and now facing the advantages of weakening, quality control and many other challenges. Recently, the Ministry of Science and Technology, the State Administration of Traditional Chinese Medicine jointly issued the "thirteen five" special scientific and technological innovation of traditional Chinese medicine planning ", put forward the development of cutting-edge key technologies and innovative methods to enhance the prevention and treatment of major diseases such as the next five years, Promote the realization of traditional Chinese medicine creative transformation, innovative development.

      How traditional Chinese medicine leverages the development of technology? Planning emphasizes the development of cutting-edge key technologies and innovative methods to strengthen the cross-cutting technology and the depth of cross-cutting traditional Chinese medicine, and effectively promote the optimization of Chinese medicine research strategy and complex system research methods change, in-depth disclosure of syndromes, traditional Chinese medicine prescriptions Key Problems of Traditional Chinese Medicine Scientific Connotation. To 2020 to solve a number of key scientific issues restricting the development of Chinese medicine.

      Natural medicine has become the source of new drug development of the international trend has emerged, Chinese medicine research and development and traditional Chinese medicine standards of international competition is becoming increasingly fierce. In this regard, the plan proposed by 2020 to form not less than 50 pharmacopoeia standards and 100 industry standards, the completion of 5-10 varieties of proprietary Chinese medicines in Europe and the United States and other developed countries as a drug registration, to promote sound Chinese medicine standard system.

Based on the unique clinical efficacy advantages, "Twelfth Five-Year" period, 16 kinds of major diseases, Chinese medicine prevention and treatment of evidence-based evidence. In order to make the traditional Chinese gemstones better play a role in the treatment of major diseases in the synergies and rehabilitation of the disease in the core role of the planning pointed out that the choice of major diseases, refractory disease, the system to carry out clinical evaluation, efficacy mechanism and individualized syndrome differentiation Capacity improvement and other research.

Planning also stressed that the focus of breakthroughs in traditional Chinese medicine discovery and evaluation of new drugs, Chinese medicine safety evaluation technology and other core technology bottlenecks, for the creation of major new drugs to provide the source of innovation.